calmidazolium and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

calmidazolium has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayel, İ; Emre, M; Kıroğlu, OE; Kumcu, EK; Özü, ÖY; Seçilmiş, MA1

Other Studies

1 other study(ies) available for calmidazolium and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

ArticleYear
Residual NO modulates contractile responses and membrane potential in isolated rat mesenteric arteries.
    Nitric oxide : biology and chemistry, 2017, Dec-01, Volume: 71

    Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Benzoates; Free Radical Scavengers; Hydroxocobalamin; Imidazoles; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Protein Kinase Inhibitors; Rats, Wistar

2017